Growth Metrics

Ultragenyx Pharmaceutical (RARE) EPS (Basic) (QoQ) (2013 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Ultragenyx Pharmaceutical 2.29 Bn 1.89 Bn 106.00 Mn

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -43.75%
Dec 31, 2025 29.28%
Sep 30, 2025 -54.70%
Jun 30, 2025 25.48%
Mar 31, 2025 -13.77%
Dec 31, 2024 1.43%
Sep 30, 2024 7.89%
Jun 30, 2024 25.12%
Mar 31, 2024 -40.97%
Dec 31, 2023 35.43%
Sep 30, 2023 0.89%
Jun 30, 2023 3.43%
Mar 31, 2023 -7.87%
Dec 31, 2022 38.29%
Sep 30, 2022 -54.87%
Jun 30, 2022 -3.20%
Mar 31, 2022 -22.35%
Dec 31, 2021 -65.74%
Sep 30, 2021 40.33%
Jun 30, 2021 10.84%
Mar 31, 2021 -448.65%
Dec 31, 2020 67.26%
Sep 30, 2020 -369.05%
Jun 30, 2020 120.49%
Mar 31, 2020 -26.54%
Dec 31, 2019 17.35%
Sep 30, 2019 -13.95%
Jun 30, 2019 5.49%
Mar 31, 2019 -5.20%
Dec 31, 2018 0.57%
Sep 30, 2018 -64.15%
Jun 30, 2018 -268.25%
Mar 31, 2018 133.33%
Dec 31, 2017 -1.07%
Sep 30, 2017 -8.72%
Jun 30, 2017 -5.52%
Mar 31, 2017 6.86%
Dec 31, 2016 -6.71%
Sep 30, 2016 -12.33%
Jun 30, 2016 -8.15%
Mar 31, 2016 4.93%
Dec 31, 2015 -37.86%
Sep 30, 2015 -24.10%
Jun 30, 2015 -31.75%
Mar 31, 2015 -21.15%
Dec 31, 2014 -4.00%
Sep 30, 2014 -11.11%
Jun 30, 2014 47.06%
Mar 31, 2014 82.93%
Dec 31, 2013 -43.10%
Sep 30, 2013 -4.82%
Jun 30, 2013 -16.90%